Similar Articles
1241 Epirubicin, Cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma
1242 Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis
1243 Transplant benefit for patients with hepatocellular carcinoma
1244 Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C
1245 Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report
1246 Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it?
1247 Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
1248 Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma
1249 Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma
1250 Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA